BTSG

Shares of healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) jumped 9.2% in the afternoon session after the company reported third-quarter 2026 financial results and raised its full-year 2026 guidance for revenue and Adjusted EBITDA.

BrightSpring Health Services has seen its share price climb sharply over the past year, which puts a spotlight on whether the current valuation is still in line with what its earnings can support.

BrightSpring Health Services (NASDAQ:BTSG) reported third-quarter results above its forecast, with revenue rising 26% year over year to $4.2 billion and adjusted EBITDA increasing 42% to $228 million.

Key TakeawaysBrightSpring Health Services stock jumped 12% as adjusted EBITDA rose 42% and 2026 guidance went up. Gross profit per script rose 27% in what management calls the peak year for Medicare’s drug-price negotiations.

Specialty pharmacy script volume surged 29% as home health integration accelerates.

The headline numbers for BrightSpring Health Services, Inc. (BTSG) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) reported Q3 2026 results beating Wall Street’s revenue expectations, with revenue up 26.4% year on year to $4.21 billion.

BrightSpring Health Services, Inc. (BTSG) delivered earnings and revenue surprises of +10.20% and +9.17%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

BrightSpring gears up for Q3 earnings, with strong Specialty, Infusion and Provider Services growth expected to offset IRA headwinds. Can it beat estimates?